Veraxa Biotech Taps Carl von Halem as Interim CFO

Halem is no stranger to the company’s internal operations, having played a key role in Veraxa’s public listing. Board chair Oliver Baumann noted that Halem’s history with the firm, combined with his background as the former CFO of Swiss business accelerator Xlife Sciences, makes him a natural fit for the interim role. Beyond his financial leadership, Halem brings experience from his tenure as co-founder and chief operating officer at the digital platform CommeX, where he focused on strategic partnerships and public sector financing. The board expects his deep expertise in the life sciences and medical technology sectors to provide necessary stability while the search for a permanent successor concludes.